Multiple Roles for the Major Histocompatibility Complex Class I-Related 671 ,
, Receptor FcRn, Annu. Rev. Immunol, vol.18, pp.739-766, 2000.
FcRn: the neonatal Fc receptor comes of age, Nat. Rev. Immunol, vol.7, pp.715-725, 2007. ,
Targeting FcRn for the modulation of antibody 675 dynamics, Mol. Immunol, vol.67, pp.131-141, 2015. ,
, The Architect Behind the
, Immune and Nonimmune Functions of IgG and Albumin, J. Immunol. Baltim. Md, vol.678, pp.4595-4603, 2015.
The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport ,
, Homeostasis, and Fate of IgG-Fc-Coupled Drugs, J. Immunol, vol.170, pp.3528-3533, 2003.
Cell surface dynamics and cellular 682 distribution of endogenous FcRn, PloS One, vol.12, p.182695, 2017. ,
FcRn: from molecular interactions to 684 regulation of IgG pharmacokinetics and functions, Curr. Top. Microbiol. Immunol, vol.382, p.685, 2014. ,
A passionate kiss, then run: exocytosis and recycling of IgG by ,
, Trends Cell Biol, vol.15, pp.5-9, 2005.
Stoichiometry of the interaction between the 689 major histocompatibility complex-related Fc receptor and its Fc ligand, Biochemistry, vol.38, pp.9471-690, 1999. ,
The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG 11, Conformational Destabilization of Immunoglobulin G Increases the Low pH ,
, Binding Affinity with the Neonatal Fc Receptor, J. Biol. Chem, vol.291, pp.1817-1825, 2016.
Crystal Structure at 2.8 Å of an ,
Heterodimeric Fc Complex: Mechanism of pH-Dependent Binding, Mol. Cell, vol.7, pp.867-877, 2001. ,
Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms ,
, J. Biol. Chem, vol.289, pp.7812-7824, 2014.
Can the flow of medicines be improved? Fundamental pharmacokinetic and 701 pharmacological principles toward improving Phase II survival, Drug Discov. Today, vol.17, p.702, 2012. ,
Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies ,
, Drug Discov. Today Technol. 21, vol.22, pp.75-83, 2016.
Enhanced antibody half-life improves in vivo activity, Nat. Biotechnol, vol.28, pp.157-706, 2010. ,
Increasing the affinity of a human IgG1 for the neonatal Fc receptor: 708 biological consequences, J. Immunol. Baltim. Md, vol.169, pp.5171-5180, 1950. ,
Properties of Human IgG1s Engineered for Enhanced 710 Binding to the Neonatal Fc Receptor (FcRn), J. Biol. Chem, vol.281, pp.23514-23524, 2006. ,
Current progress in innovative engineered antibodies, Protein Cell, vol.9, pp.86-120, 2018. ,
pH-Dependent Binding Engineering Reveals An FcRn Affinity Threshold Which ,
, Governs IgG Recycling. J. Biol. Chem. jbc.M114, vol.603712, 2014.
, A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, p.717
Has an Extended Half-Life in Healthy Adults, Antimicrob. Agents Chemother ,
FcRn Affinity-Pharmacokinetic Relationship of Five Human IgG4 ,
, Antibodies Engineered for Improved In Vitro FcRn Binding Properties in Cynomolgus Monkeys
, Drug Metab. Dispos, vol.40, pp.1545-1555, 2012.
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for 723 all infants, Sci. Transl. Med, vol.9, 2017. ,
Enhanced neonatal Fc receptor function improves protection against primate SHIV 725 infection, Nature, vol.514, pp.642-645, 2014. ,
Divergent activities of an 727 engineered antibody in murine and human systems have implications for therapeutic antibodies ,
, Proc. Natl. Acad. Sci, vol.103, pp.18709-18714, 2006.
, FDA approved | PNH treatment
,
, Tolerability, and Pharmacokinetics of MEDI8897, p.733
, Half-Life Single-Dose Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody 734
, Administered as a Single Dose to Healthy Preterm Infants, Pediatr. Infect. Dis. J, p.735, 2018.
, Monoclonal Antibody, vol.30
, Neonatal Fc Receptor: Relationship to Pharmacokinetics in Mice and Primates, Drug Metab
, , vol.35, pp.86-94, 2007.
Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-743 CD4 monoclonal antibody from preclinical model to phase I study, Clin. Pharmacol. Ther, vol.89, pp.283-290, 2011. ,
The contribution of cell surface FcRn in monoclonal antibody serum uptake 746 from the intestine in suckling rat pups, Front. Pharmacol, vol.5, 2014. ,
Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn 748 Differentially with Pharmacokinetic Consequences, Drug Metab. Dispos, vol.39, pp.1469-1477, 2011. ,
An 'Fc-Silenced' IgG1 Format With Extended Half-Life Designed for Improved ,
, J. Pharm. Sci, vol.106, pp.1008-1017, 2017.
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor 752 ,
, Affects Fc Effector Functions, J. Immunol, vol.194, pp.5497-5508, 2015.
, ThomasJ. Human FcRn, vol.754
, Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies, Mouse Models for
, , p.756, 2016.
Humanized FcRn mouse models for evaluating pharmacokinetics 758 of human IgG antibodies, Methods San Diego Calif, vol.65, pp.148-153, 2014. ,
,
, Across Species and Tissues, J. Histochem. Cytochem. Off. J. Histochem. Soc, vol.65, pp.321-333, 2017.
,
Correlations between 765 pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model 766 with predictive capabilities, mAbs, vol.5, pp.397-405, 2013. ,
Targeted Fc? Receptor (Fc?R)-mediated Clearance by a Biparatopic 768 ,
, Bispecific Antibody. J. Biol. Chem, vol.292, pp.4361-4370, 2017.
Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis 770 patients exacerbate disease in a humanized mouse model, J. Autoimmun, vol.86, pp.104-115, 2018. ,
Effective Phagocytosis of Low Her2 Tumor Cell Lines with Engineered, p.772 ,
, Aglycosylated IgG Displaying High Fc?RIIa Affinity and Selectivity, ACS Chem. Biol, vol.8, pp.368-375, 2012.
IgG Fc domains that bind C1q but not effector Fc? receptors delineate the 775 importance of complement-mediated effector functions, Nat. Immunol, vol.18, pp.889-898, 2017. ,
Anchored periplasmic expression, a versatile technology for the isolation of 777 high-affinity antibodies from Escherichia coli-expressed libraries, Proc. Natl. Acad. Sci. U. S. A, vol.778, pp.9193-9198, 2004. ,
An Engineered Human Fc variant with Exquisite Selectivity for Fc?RIIIaV158 ,
, Reveals that Ligation of Fc?RIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis 781 with GM-CSF-differentiated Macrophages, Front. Immunol, vol.10, 2019.
Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal 783 antibodies, J. Am. Chem. Soc, vol.135, pp.9723-9732, 2013. ,
Selection of IgG Variants with Increased FcRn Binding Using Random and 785 ,
, Directed Mutagenesis: Impact on Effector Functions. Front. Immunol, vol.6, 2015.
Mechanisms of anaphylaxis in human low-affinity IgG receptor locus knock-in 789 mice, J. Allergy Clin. Immunol, vol.139, 2017. ,
Platelets expressing IgG receptor Fc?RIIA/CD32A determine the severity of 791 experimental anaphylaxis, Sci. Immunol, vol.3, p.5997, 2018. ,
Properties of mouse and human IgG receptors and their contribution to disease 793 models, Blood, vol.119, pp.5640-5649, 2012. ,
The Immunopathology of Joint Inflammation in Rheumatoid Arthritis11Original 795 work described in this review has been aided by grants ,
, National Institutes of Health, Advances in Immunology
Rheumatoid factors: clinical applications, Dis. Markers, vol.799, pp.727-734, 2013. ,
Rheumatoid factors: host resistance or autoimmunity?, Clin. Immunol. Orlando ,
, Fla, vol.104, pp.1-13, 2002.
Mast cells: a cellular link between autoantibodies and inflammatory arthritis ,
, Science, vol.297, pp.1689-1692, 2002.
Developability Assessment During the Selection of Novel Therapeutic ,
, J. Pharm. Sci, vol.104, pp.1885-1898, 2015.
Biophysical properties of the clinical-stage antibody landscape, Proc. Natl. Acad. Sci ,
, , vol.114, pp.944-949, 2017.
Specificity and affinity of human Fc? receptors and their polymorphic variants 814 for human IgG subclasses, Blood, vol.113, pp.3716-3725, 2009. ,
Crosstalk between Human IgG Isotypes and Murine Effector Cells ,
, , vol.189, pp.3430-3438, 2012.
Clinical chemistry of human FcRn transgenic mice, Mamm. Genome Off. J. Int ,
, Mamm. Genome Soc, vol.23, pp.259-269, 2012.
Progress and Challenges 820 in the Design and Clinical Development of Antibodies for Cancer Therapy, Front. Immunol, vol.8, p.821, 2018. ,
expression and characterization of a soluble single-823 chain functional human neonatal Fc receptor, Protein Expr. Purif, vol.79, pp.66-71, 2011. ,
IgGA: a 'cross-isotype' engineered human Fc antibody domain that displays 825 both IgG-like and IgA-like effector functions, Chem. Biol, vol.21, pp.1603-1609, 2014. ,
Enhanced crossover SCRATCHY: construction and high-throughput 827 screening of a combinatorial library containing multiple non-homologous crossovers ,
, Acids Res, vol.31, p.126, 2003.
The major histocompatibility complex-related Fc receptor for IgG (FcRn) 830 binds albumin and prolongs its lifespan, J. Exp. Med, vol.197, pp.315-322, 2003. ,
, Stan: A Probabilistic Programming Language | Carpenter, Journal of Statistical Software, vol.832, p.69
, SINS) assay. Data are from one experiment representative of three experiments using three individual 882 donors (a-d). Errors in all plots and tables represent standard deviations from triplicate experiments